According to Avid Bioservices
's latest financial reports the company has a price-to-book ratio of 2.54.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.24 | -52.74% |
2022-12-31 | 4.74 | -86.53% |
2021-12-31 | 35.2 | 148.48% |
2020-12-31 | 14.2 | 61.07% |
2019-12-31 | 8.79 | 109.43% |
2018-12-31 | 4.20 | 2.6% |
2017-12-31 | 4.09 | 117.46% |
2016-12-31 | 1.88 | -51.57% |
2015-12-31 | 3.88 | -9.84% |
2014-12-31 | 4.31 | -31.12% |
2013-12-31 | 6.25 | -54.73% |
2012-12-31 | 13.8 | 93.03% |
2011-12-31 | 7.15 | -43.44% |
2010-12-31 | 12.6 | -31.16% |
2009-12-31 | 18.4 | 82.2% |
2008-12-31 | 10.1 | 230.78% |
2007-12-31 | 3.05 | -67.4% |
2006-12-31 | 9.35 | -27.92% |
2005-12-31 | 13.0 | -27.83% |
2004-12-31 | 18.0 | -33.58% |
2003-12-31 | 27.1 | 44.14% |
2002-12-31 | 18.8 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Neogen NEOG | 0.8354 | -67.16% | ๐บ๐ธ USA |
Natera NTRA | 14.6 | 475.87% | ๐บ๐ธ USA |